All In Biotech

Drug Trial Radar · NCT06527404

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies

Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 469 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

469

Actual

Start

Jul 18, 2024

Primary completion

Apr 17, 2026

Study completion Jun 25, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jul 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).

Conditions

  • Prurigo Nodularis

Interventions

  • RocatinlimabDrug

    SC Injection

  • PlaceboDrug

    SC Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Global: Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score at Week 24Time frame: Up to 24 weeks
  2. US Only: Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score and Prurigo Nodularis Stage Assessment at Week 24Time frame: Up to 24 weeks

Locations

192 sites in 30 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • First OC Dermatology

    Fountain Valley, California

  • Los Angeles Universal Research Center

    Los Angeles, California

  • Paradigm Clinical Research Center Inc

    San Diego, California

  • Wolverine Clinical Trials

    Santa Ana, California

  • Direct Helpers Research Center

    Hialeah, Florida

  • Southern Clinical Research

    Miami, Florida

  • University of Miami Hospital

    Miami, Florida

  • Miami Dermatology and Laser Institute

    Miami, Florida

  • Wellness Clinical Research

    Miami Lakes, Florida

  • Clinical Research Trials of Florida Inc

    Tampa, Florida

  • Olympian Clinical Research - Tampa

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • Endeavor Health Clinical Trials Center

    Skokie, Illinois

  • The Indiana Clinical Trials Center PC

    Plainfield, Indiana

  • Revival Research Institute, LLC

    Troy, Michigan

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Optima Research

    Boardman, Ohio

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Wright State Physicians

    Fairborn, Ohio

  • Hightower Clinical

    Oklahoma City, Oklahoma

  • Center For Clinical Studies PLLC

    Houston, Texas

  • Clarity Dermatology

    Lancaster, Texas

  • Springville Dermatology

    Springville, Utah

  • Parra Dermatologia

    Mendoza, Argentina

  • Hospital Universitario Austral

    Derqui, Pilar, Buenos Aires, Argentina

  • Instituto de Investigaciones Clinicas de Cordoba

    Córdoba, Córdoba Province, Argentina

  • Instituto de Neumonologia y Dermatologia

    Buenos Aires, Distrito Federal, Argentina

  • Derma Internacional

    Buenos Aires, Distrito Federal, Argentina

  • Centro de investigacion clinica y epidemiologica

    San Miguel D Tucuman, Tucumán Province, Argentina

  • St George Dermatology and Skin Cancer Centre

    Kogarah, New South Wales, Australia

  • Veracity Clinical Research

    Woolloongabba, Queensland, Australia

  • Box Hill Hospital

    Box Hill, Victoria, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • The Royal Melbourne Hospital

    Parkville, Victoria, Australia

  • Medizinische Universitaet Graz

    Graz, Austria

  • Ordensklinikum Linz Elisabethinen

    Linz, Austria

  • Universite Catholique de Louvain Cliniques Universitaires Saint Luc

    Brussels, Belgium

  • Universitaire Ziekenhuizen Leuven Gasthuisberg

    Leuven, Belgium

  • Centre Hospitalier Universitaire de Liege - Sart Tilman

    Liège, Belgium

Showing 40 of 192 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.